Case number 2:23-cv-01190
CATALYST PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS, INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 10, 2025 | 175 | CONSENT JUDGMENT in favor of CATALYST PHARMACEUTICALS, INC., SERB SA against TEVA PHARMACEUTICALS USA, INC.; CIVIL CASE TERMINATED. Signed by Judge Michael E. Farbiarz on 1/10/2025. (mxw, ) (Entered: 01/10/2025) (3) |
| Jan 8, 2025 | 174 | Letter from Charles H. Chevalier to The Honorable Michael E. Farbiarz, U.S.D.J. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 01/08/2025) (0) |
| Jan 7, 2025 | 173 | ORDER granting 170 Motion to Seal. Signed by Magistrate Judge Jose R. Almonte on 1/7/2025. (adc) (Entered: 01/07/2025) (4) |
| Jan 6, 2025 | 170 | MOTION to Seal ECF Nos. 167, 168, and 168-1 by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Declaration of Charles H. Chevalier, # 2 Index, # 3 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 01/06/2025) (0) |
| Jan 6, 2025 | 171 | REDACTION to 167 Response (NOT Motion),, by CATALYST PHARMACEUTICALS, INC., SERB SA. (CHEVALIER, CHARLES) (Entered: 01/06/2025) (20) |
| Jan 6, 2025 | 172 | REDACTION to 168 Markman Response Brief,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Exhibit 39)(CHEVALIER, CHARLES) (Entered: 01/06/2025) (0) |
| Dec 23, 2024 | 167 | RESPONSE re 157 Order, Terminate Motions. (Attachments: # 1 Declaration of Brian L. O'Gara in Support of Defendants' Additional Responsive Claim Construction Brief, # 2 Exhibit 26 (Deposition Transcript of Charlene McQueen, Ph.D.))(ABRAHAM, ERIC)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 12/23/2024) (0) |
| Dec 23, 2024 | 168 | MARKMAN RESPONSE BRIEF re 66 Markman Opening Brief, (Attachments: # 1 Exhibit 39)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 12/23/2024) (0) |
| Dec 23, 2024 | 169 | DECLARATION of Lauren Watt re 168 Markman Response Brief,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Exhibit 40)(CHEVALIER, CHARLES) (Entered: 12/23/2024) (0) |
| Dec 2, 2024 | 166 | Transcript of Motion Hearing held on November 22, 2024, before Judge Michael E. Farbiarz. Court Reporter: Lisa Larsen (973-776-7741). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter due, but not filed, by 12/23/2024. Redacted Transcript Deadline set for 1/2/2025. Release of Transcript Restriction set for 3/3/2025. (adc) (Entered: 12/03/2024) (25) |
| Nov 22, 2024 | 163 | Minute Entry for proceedings held before Judge Michael E. Farbiarz: Motion Hearing held on 11/22/2024 re 125 APPEAL OF MAGISTRATE JUDGE DECISION to District Court by CATALYST PHARMACEUTICALS, INC., SERB SA re 116 Order filed by CATALYST PHARMACEUTICALS, INC., SERB SA. (Court Reporter, Lisa Larsen (973-776-7741)) (ro, ) (Entered: 11/22/2024) (1) |
| Nov 22, 2024 | 164 | TEXT ORDER: The appeal [ECF 125] is denied. The decision of United States Magistrate Judge Almonte [ECF 116] is affirmed for the reasons set out during oral argument on November 22, 2024. So Ordered by Judge Michael E. Farbiarz on 11/22/2024. (ro, ) (Entered: 11/22/2024) (0) |
| Nov 22, 2024 | 165 | TEXT ORDER: The Defendants' request to defer findings on indefiniteness [ECF 52 & 160] is denied. Parties shall proceed with the discovery related to indefiniteness as ordered at ECF 157 & 162. So Ordered by Judge Michael E. Farbiarz on 11/22/2024. (ro, ) (Entered: 11/22/2024) (0) |
| Nov 19, 2024 | 162 | TEXT ORDER: The Court is in receipt of the parties' letter (ECF No. 161 ) with their positions regarding the scheduling of additional Markman expert discovery. The parties shall proceed with discovery as follows: Expert depositions related to Markman shall be completed by December 13, 2024. Supplemental claim construction briefs shall be due by December 23, 2024. So Ordered by Magistrate Judge Jose R. Almonte on 11/19/2024. (akw, ) (Entered: 11/20/2024) (0) |
| Nov 15, 2024 | 161 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. (CHEVALIER, CHARLES) (Entered: 11/15/2024) (2) |
| Nov 14, 2024 | 160 | Letter from Charles H. Chevalier, Esq. to the Honorable Michael E. Farbiarz, U.S.D.J.. (CHEVALIER, CHARLES) (Entered: 11/14/2024) (2) |
| Nov 12, 2024 | 158 | TEXT ORDER: Oral argument on the appeal at ECF 125 will take place in person on November 22 at 10:00am. So Ordered by Judge Michael E. Farbiarz on 11/12/2024. (ro, ) (Entered: 11/12/2024) (0) |
| Nov 12, 2024 | 159 | Letter from Charles H. Chevalier to The Honorable Michael E. Farbiarz, U.S.D.J. (CHEVALIER, CHARLES) (Entered: 11/12/2024) (2) |
| Nov 7, 2024 | 157 | LETTER ORDER addressing competing motions to strike. Signed by Magistrate Judge Jose R. Almonte on 11/7/2024. (mxw, ) (Entered: 11/07/2024) (0) |
| Sep 30, 2024 | 156 | LETTER ORDER granting the requested extensions to expert report deadlines as set forth in Defendants' 155 Letter. Signed by Magistrate Judge Jose R. Almonte on 9/30/2024. (mxw, ) (Entered: 09/30/2024) (1) |
| Sep 27, 2024 | 155 | Letter from Douglas Weider. (WEIDER, DOUGLAS) (Entered: 09/27/2024) (2) |
| Sep 23, 2024 | 154 | LETTER ORDER granting 153 Defendant's request for an extension of the fact discovery deadlines, until 9/27/2024. Signed by Magistrate Judge Jose R. Almonte on 9/23/2024. (jd, ) Modified on 9/23/2024 (jd, ). (Entered: 09/23/2024) (1) |
| Sep 20, 2024 | 153 | Letter from Douglas Weider re 152 Order, Terminate Deadlines, Set Deadlines. (WEIDER, DOUGLAS) (Entered: 09/20/2024) (1) |
| Sep 16, 2024 | 151 | LETTER ORDER granting the parties' 149 Letter request to conduct a deposition after the current deadline for fact discovery. Signed by Magistrate Judge Jose R. Almonte on 9/16/2024. (mxw, ) (Entered: 09/16/2024) (1) |
| Sep 16, 2024 | 152 | LETTER ORDER granting the parties' 150 Letter request to extend the deadline for fact discovery to 9/20/2024. Signed by Magistrate Judge Jose R. Almonte on 9/16/2024. (mxw, ) Modified on 9/18/2024 (mxw, ). (Entered: 09/16/2024) (1) |
| Sep 13, 2024 | 149 | Letter from Charles H. Chevalier to the Honorable Jose R. Almonte, U.S.M.J.. (CHEVALIER, CHARLES) (Entered: 09/13/2024) (1) |
| Sep 13, 2024 | 150 | Letter from Douglas R. Weider re 147 Letter. (WEIDER, DOUGLAS) (Entered: 09/13/2024) (1) |
| Sep 9, 2024 | 148 | LETTER ORDER granting Plaintiff's 147 Letter request to extend the fact discovery deadline to 9/13/2024. Signed by Magistrate Judge Jose R. Almonte on 9/9/2024. (mxw, ) (Entered: 09/09/2024) (1) |
| Sep 6, 2024 | 147 | Letter from Charles H. Chevalier to the Honorable Jose R. Almonte, U.S.M.J.. (CHEVALIER, CHARLES) (Entered: 09/06/2024) (1) |
| Sep 3, 2024 | 146 | JOINT STIPULATION AND ORDER extending the deadline for completion of fact discovery to 9/6/2024. Signed by Magistrate Judge Jose R. Almonte on 9/3/2024. (mxw, ) (Entered: 09/04/2024) (5) |
| Aug 30, 2024 | 145 | STIPULATION and Proposed Order for Limited Extension of Fact Discovery by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (WEIDER, DOUGLAS) (Entered: 08/30/2024) (5) |
| Aug 12, 2024 | 144 | TEXT ORDER: A status conference is scheduled for August 20, 2024, at 4:00 p.m. For the conference, please dial 973-437-5535 and enter Phone conference ID: 577 551 351#. The purpose of the conference is to discuss whether, in light of recent developments in the cases, the Court still needs to decide (1) Lupin's motion to compel Plaintiffs to supplement their infringement contentions (ECF No. 80 in the Lupin Action), (2) the parties' competing motions to strike Markman Hearing submissions, and (3) the discovery dispute raised at ECF No. 161 in the Lupin action. So Ordered by Magistrate Judge Jose R. Almonte on 8/12/2024. (akw, ) (Entered: 08/12/2024) (0) |
| Jul 16, 2024 | 141 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. (CHEVALIER, CHARLES) (Entered: 07/16/2024) (1) |
| Jul 16, 2024 | 142 | ORDER granting 140 Motion for Leave for ANDREW Z. BARNETT, ESQ. to Appear Pro Hac Vice. Signed by Magistrate Judge Jose R. Almonte on 7/16/2024. (mxw, ) (Entered: 07/16/2024) (3) |
| Jul 16, 2024 | 143 | Notice of Request by Pro Hac Vice Andrew Z. Barnett to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 250 receipt number ANJDC-15521839.) (CHEVALIER, CHARLES) (Entered: 07/16/2024) (1) |
| Jul 15, 2024 | 140 | MOTION for Leave to Appear Pro Hac Vice by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Declaration of Charles H. Chevalier, # 2 Declaration of Andrew Z. Barnett, # 3 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 07/15/2024) (0) |
| Jul 1, 2024 | 138 | TEXT ORDER: In light of our order at ECF No. 137 which sealed the exhibit at ECF No. 134 , the Court orders the seal of the transcript at ECF No. 132 , which is identical to the exhibit sealed at 134 . The parties may write to the Court within seven (7) business days if they wish to object. So Ordered by Magistrate Judge Jose R. Almonte on 7/1/2024. (akw, ) Modified on 7/2/2024 (akw, ). (Entered: 07/01/2024) (0) |
| Jul 1, 2024 | 139 | SEALED LETTER ORDER. Signed by Magistrate Judge Jose R. Almonte on 7/1/2024. (mxw, ) (Entered: 07/02/2024) (0) |
| Jun 25, 2024 | 137 | ORDER granting Defendants' 136 Motion to Seal. Signed by Magistrate Judge Jose R. Almonte on 6/25/2024. (mxw, ) (Entered: 06/26/2024) (5) |
| Jun 24, 2024 | 136 | MOTION to Seal by All Defendants. (Attachments: # 1 Text of Proposed Order, # 2 Declaration, # 3 Exhibit Index, # 4 Exhibit, # 5 Exhibit, # 6 Exhibit, # 7 Exhibit)(MURTHA, WILLIAM) (Entered: 06/24/2024) (0) |
| Jun 10, 2024 | 135 | REPLY to Response to Motion filed by CATALYST PHARMACEUTICALS, INC., SERB SA re 125 APPEAL OF MAGISTRATE JUDGE DECISION to District Court by CATALYST PHARMACEUTICALS, INC., SERB SA re 116 Order (CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 06/10/2024) (0) |
| Jun 3, 2024 | 132 | RESPONSE in Opposition filed by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. re 125 APPEAL OF MAGISTRATE JUDGE DECISION to District Court by CATALYST PHARMACEUTICALS, INC., SERB SA re 116 Order (WEIDER, DOUGLAS)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 06/03/2024) (0) |
| Jun 3, 2024 | 133 | Letter from Charles H. Chevalier to The Honorable Michael E. Farbiarz, U.S.D.J. (CHEVALIER, CHARLES) (Entered: 06/03/2024) (1) |
| Jun 3, 2024 | 134 | Exhibit to 133 Letter by CATALYST PHARMACEUTICALS, INC., SERB SA. (CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 06/03/2024) (0) |
| May 31, 2024 | 131 | ORDER granting Plaintiffs' 128 Motion to Seal. Signed by Magistrate Judge Jose R. Almonte on 5/31/2024. (mxw, ) (Entered: 05/31/2024) (4) |
| May 29, 2024 | 128 | MOTION to Seal by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Declaration of Charles H. Chevalier, # 2 Index, # 3 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 05/29/2024) (0) |
| May 29, 2024 | 129 | REDACTION to 118 Brief in Opposition to Motion,,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (CHEVALIER, CHARLES) (Entered: 05/29/2024) (30) |
| May 29, 2024 | 130 | REDACTION to 112 Memorandum in Support of Motion,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(CHEVALIER, CHARLES) (Entered: 05/29/2024) (0) |
| May 21, 2024 | 127 | LETTER ORDER granting Defendants' 124 Letter request for the Court's 5/3/2024 Letter Order to remain under seal. Signed by Magistrate Judge Jose R. Almonte on 5/21/2024. (mxw, ) (Entered: 05/21/2024) (7) |
| May 17, 2024 | 124 | Letter from Eric Abraham To the Honorable Jose R. Almonte, U.S.M.J. with redacted Letter Order. (Attachments: # 1 Supplement Redacted Order)(MURTHA, WILLIAM) (Entered: 05/17/2024) (0) |
| May 17, 2024 | 125 | APPEAL OF MAGISTRATE JUDGE DECISION to District Court by CATALYST PHARMACEUTICALS, INC., SERB SA re 116 Order (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 05/17/2024) (0) |
| May 17, 2024 | 126 | MEMORANDUM in Support filed by CATALYST PHARMACEUTICALS, INC., SERB SA re 125 APPEAL OF MAGISTRATE JUDGE DECISION to District Court by CATALYST PHARMACEUTICALS, INC., SERB SA re 116 Order (CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 05/17/2024) (0) |
| May 15, 2024 | 122 | RESPONSE in Support filed by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. re 110 MOTION to Strike (WEIDER, DOUGLAS) (Entered: 05/15/2024) (21) |
| May 15, 2024 | 123 | REPLY BRIEF to Opposition to Motion filed by CATALYST PHARMACEUTICALS, INC., SERB SA re 111 MOTION to Strike 92 Markman Response Brief,,, (Attachments: # 1 Declaration of Lauren Watt, # 2 Exhibit E)(CHEVALIER, CHARLES) (Entered: 05/15/2024) (0) |
| May 9, 2024 | 121 | Notice of Request by Pro Hac Vice Cristen A. Corry to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 250 receipt number ANJDC-15353644.) (CHEVALIER, CHARLES) (Entered: 05/09/2024) (1) |
| May 8, 2024 | 120 | ORDER granting 119 Motion for Leave for CRISTEN A. CORRY, ESQ. to Appear Pro Hac Vice. Signed by Magistrate Judge Jose R. Almonte on 5/8/2024. (mxw, ) (Entered: 05/08/2024) (3) |
| May 7, 2024 | 119 | MOTION for Leave to Appear Pro Hac Vice of Cristen A. Corry by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Declaration of Charles H. Chevalier, # 2 Declaration of Cristen A. Corry, # 3 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 05/07/2024) (0) |
| May 3, 2024 | 116 | LETTER ORDER denying Plaintiffs' request to compel the production of stability samples. Signed by Magistrate Judge Jose R. Almonte on 5/3/2024. (mxw, ) (Entered: 05/03/2024) (0) |
| May 3, 2024 | 117 | BRIEF in Opposition filed by CATALYST PHARMACEUTICALS, INC., SERB SA re 110 MOTION to Strike (Attachments: # 1 Declaration of Lauren Watt, Esq., # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(CHEVALIER, CHARLES) (Entered: 05/03/2024) (0) |
| May 3, 2024 | 118 | BRIEF in Opposition filed by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. re 111 MOTION to Strike 92 Markman Response Brief,,, (Attachments: # 1 Declaration of Alison King, # 2 Exhibit Exhibit 1, # 3 Exhibit Exhibit 2, # 4 Exhibit Exhibit 3, # 5 Exhibit Exhibit 4, # 6 Exhibit Exhibit 5, # 7 Exhibit Exhibit 6, # 8 Exhibit Exhibit 7, # 9 Exhibit Appendix A)(WEIDER, DOUGLAS)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 05/03/2024) (0) |
| May 2, 2024 | 115 | LETTER ORDER granting the parties' joint 113 Letter request to unseal documents. Signed by Magistrate Judge Jose R. Almonte on 5/2/2024. (mxw, ) (Entered: 05/03/2024) (2) |
| Apr 30, 2024 | 113 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. (CHEVALIER, CHARLES) (Entered: 04/30/2024) (2) |
| Apr 26, 2024 | 114 | Transcript of Status Conference held on April 24, 2024, before Magistrate Judge Jose R. Almonte. Transcriber: King Transcription Services (973-237-6080). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Transcription Agency due, but not filed, by 5/17/2024. Redacted Transcript Deadline set for 5/28/2024. Release of Transcript Restriction set for 7/25/2024. (adc) (Entered: 05/02/2024) (0) |
| Apr 19, 2024 | 108 | ORDER granting Defendant's 104 Motion to Seal entry No. 89-1. Signed by Magistrate Judge Jose R. Almonte on 4/19/2024. (mxw, ) (Entered: 04/19/2024) (4) |
| Apr 19, 2024 | 109 | LETTER ORDER granting the parties' request as set forth in the parties' joint letter dated 4/18/2024 that the parties be allowed to submit a joint status letter within three days of the resolution of forthcoming motions to strike. Signed by Judge Michael E. Farbiarz on 4/19/2024. (mxw, ) Modified on 4/22/2024 (ams, ). (Entered: 04/19/2024) (2) |
| Apr 19, 2024 | 110 | MOTION to Strike by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (Attachments: # 1 Brief, # 2 Declaration of Alison King, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Text of Proposed Order)(WEIDER, DOUGLAS) (Entered: 04/19/2024) (0) |
| Apr 19, 2024 | 111 | MOTION to Strike 92 Markman Response Brief,,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Declaration of Lauren Watt, Esq., # 2 Exhibit D, # 3 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 04/19/2024) (0) |
| Apr 19, 2024 | 112 | MEMORANDUM in Support filed by SERB SA re 111 MOTION to Strike 92 Markman Response Brief,,, (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 04/19/2024) (0) |
| Apr 18, 2024 | 106 | Letter from Douglas Weider re 105 Order, 104 MOTION to Seal . (WEIDER, DOUGLAS) (Entered: 04/18/2024) (1) |
| Apr 18, 2024 | 107 | Letter from Charles H. Chevalier to The Honorable Michael E. Farbiarz, U.S.D.J re 103 Order,. (CHEVALIER, CHARLES) (Entered: 04/18/2024) (2) |
| Apr 17, 2024 | 105 | TEXT ORDER: The Court is in receipt of Defendants' motion to seal (ECF No. 104 ). Defendants shall clarify whether the exhibit they wish to seal is document ECF No. 89-1 or ECF No. 90-1. So Ordered by Magistrate Judge Jose R. Almonte on 4/17/2024. (akw, ) (Entered: 04/18/2024) (0) |
| Apr 16, 2024 | 104 | MOTION to Seal by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (Attachments: # 1 Declaration Declaration of Alison King, # 2 Exhibit Exhibit 1, # 3 Text of Proposed Order)(WEIDER, DOUGLAS) (Entered: 04/16/2024) (0) |
| Apr 15, 2024 | 103 | TEXT ORDER: The Court understands the parties letter at Docket Entry 121 to suggest the Markman hearing should be held after some or all of the parties various open motions have been resolved by Judge Almonte. The parties shall file a brief joint letter on or before April 18 explaining which of these open motions they believe should be resolved prior to holding the Markman hearing. So Ordered by Judge Michael E. Farbiarz on 4/15/2024. (ro, ) (Entered: 04/15/2024) (0) |
| Apr 12, 2024 | 101 | ORDER granting Plaintiffs' 97 Motion to Seal. Signed by Magistrate Judge Jose R. Almonte on 4/12/2024. (mxw, ) (Entered: 04/12/2024) (4) |
| Apr 12, 2024 | 102 | LETTER ORDER adopting the proposed briefing schedule for motions to strike as set forth in the parties' joint 98 Letter request. Signed by Magistrate Judge Jose R. Almonte on 4/12/2024. (mxw, ) (Entered: 04/12/2024) (2) |
| Apr 11, 2024 | 97 | MOTION to Seal by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Declaration of Charles H. Chevalier, # 2 Index, # 3 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 04/11/2024) (0) |
| Apr 11, 2024 | 98 | Letter from Douglas Weider. (WEIDER, DOUGLAS) (Entered: 04/11/2024) (2) |
| Apr 11, 2024 | 99 | REDACTION to 92 Markman Response Brief,,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Exhibit 21, # 2 Declaration of Samuel Pleasure, M.D., Ph.D.)(CHEVALIER, CHARLES) (Entered: 04/11/2024) (0) |
| Apr 11, 2024 | 100 | Letter from Charles H. Chevalier to The Honorable Michael E. Farbiarz, U.S.D.J. (CHEVALIER, CHARLES) (Entered: 04/11/2024) (2) |
| Apr 3, 2024 | 96 | ORDER granting Defendants' 94 Motion to Seal. Signed by Magistrate Judge Jose R. Almonte on 4/3/2024. (mxw, ) (Entered: 04/03/2024) (5) |
| Apr 2, 2024 | 93 | REPLY BRIEF to Opposition to Motion filed by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. re 81 MOTION to Amend/Correct Invalidity Contentions (WEIDER, DOUGLAS) (Entered: 04/02/2024) (22) |
| Apr 2, 2024 | 94 | MOTION to Seal by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (Attachments: # 1 Declaration Declaration of Alison M. King, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Declaration Declaration of William Murtha, # 8 Exhibit 1, # 9 Declaration Declaration of James Richter, # 10 Text of Proposed Order)(WEIDER, DOUGLAS) (Entered: 04/02/2024) (0) |
| Apr 2, 2024 | 95 | *REDACTED* Transcript of Status Conference held on February 13, 2024, before Magistrate Judge Jose R. Almonte. Transcriber: King Transcription Services (973-237-6080). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Transcription Agency due, but not filed, by 4/23/2024. Redacted Transcript Deadline set for 5/3/2024. Release of Transcript Restriction set for 7/1/2024. (adc) (Entered: 04/03/2024) (44) |
| Mar 28, 2024 | 91 | MARKMAN RESPONSE BRIEF re 66 Markman Opening Brief, (Attachments: # 1 Declaration of Lauren Watt, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Exhibit 32, # 17 Exhibit 33, # 18 Exhibit 34, # 19 Exhibit 35, # 20 Exhibit 36, # 21 Exhibit 37, # 22 Exhibit 38)(CHEVALIER, CHARLES) (Entered: 03/28/2024) (0) |
| Mar 28, 2024 | 92 | MARKMAN RESPONSE BRIEF re 66 Markman Opening Brief, (Attachments: # 1 Declaration Declaration of Alison M. King, # 2 Exhibit 21 (Under seal), # 3 Exhibit 22, # 4 Exhibit 23, # 5 Exhibit 24, # 6 Exhibit 25, # 7 Declaration Declaration of Salvatore D. Lepore, Ph.D., # 8 Declaration Declaration of Samuel Pleasure, M.D., Ph.D. (Under Seal))(WEIDER, DOUGLAS)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 03/28/2024) (0) |
| Mar 19, 2024 | 87 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. re 85 Brief,,. (Attachments: # 1 Exhibit J, # 2 Exhibit K, # 3 Exhibit L)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 03/19/2024) (0) |
| Mar 19, 2024 | 88 | Exhibit to 87 Letter,, Exhibit M by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Exhibit N, # 2 Exhibit O, # 3 Exhibit P, # 4 Exhibit Q, # 5 Exhibit R, # 6 Exhibit S, # 7 Exhibit T)(CHEVALIER, CHARLES) (Entered: 03/19/2024) (0) |
| Mar 19, 2024 | 89 | RESPONSE in Opposition filed by CATALYST PHARMACEUTICALS, INC., SERB SA re 81 MOTION to Amend/Correct Invalidity Contentions (Attachments: # 1 Exhibit 1)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 03/19/2024) (0) |
| Mar 19, 2024 | 90 | DECLARATION re 89 Response in Opposition to Motion,, Declaration of Alex Alfano by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Exhibit 4, # 2 Exhibit 5, # 3 Exhibit 6, # 4 Exhibit 7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Exhibit 12, # 10 Exhibit 13, # 11 Exhibit 14, # 12 Exhibit 15)(CHEVALIER, CHARLES) (Entered: 03/19/2024) (0) |
| Mar 14, 2024 | 86 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. re 84 Order. (CHEVALIER, CHARLES) (Entered: 03/14/2024) (2) |
| Mar 12, 2024 | 84 | TEXT ORDER: By March 14, 2024, the parties shall file a joint letter informing the Court whether the issues raised at ECF No. 74 have been resolved. See ECF No. 75 .. So Ordered by Magistrate Judge Jose R. Almonte on 3/12/2024. (akw, ) (Entered: 03/12/2024) (0) |
| Mar 12, 2024 | 85 | BRIEF (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(WEIDER, DOUGLAS)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 03/12/2024) (0) |
| Feb 27, 2024 | 81 | MOTION to Amend/Correct Invalidity Contentions by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (Attachments: # 1 Brief Opening Brief, # 2 Declaration of Sharon Lin, # 3 Text of Proposed Order)(WEIDER, DOUGLAS) (Entered: 02/27/2024) (0) |
| Feb 27, 2024 | 82 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. (Attachments: # 1 Exhibit C, # 2 Exhibit F, # 3 Exhibit G, # 4 Exhibit H)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 02/27/2024) (0) |
| Feb 27, 2024 | 83 | Exhibit to 82 Letter,, Exhibit A by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Exhibit B, # 2 Exhibit D, # 3 Exhibit E, # 4 Exhibit I)(CHEVALIER, CHARLES) (Entered: 02/27/2024) (0) |
| Feb 21, 2024 | 79 | ORDER granting Defendants' 78 Motion to Seal. Signed by Magistrate Judge Jose R. Almonte on 2/21/2024. (mxw, ) (Entered: 02/21/2024) (4) |
| Feb 21, 2024 | 80 | TEXT ORDER: The Court adopts the parties' proposed briefing schedule for Defendants' proposed motion for leave to amend their invalidity contentions (ECF No. 77 ). Defendants shall file their opening brief on or before February 27, 2024. Plaintiffs shall file their opposition brief on or before March 19, 2024. Defendants shall file their reply brief on or before April 2, 2024. So Ordered by Magistrate Judge Jose R. Almonte on 2/21/2024. (akw, ) (Entered: 02/21/2024) (0) |
| Feb 20, 2024 | 77 | Letter from Teva Pharmaceuticals, Inc., et al re consent order on briefing schedule. (WEIDER, DOUGLAS) (Entered: 02/20/2024) (2) |
| Feb 20, 2024 | 78 | MOTION to Seal by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (Attachments: # 1 Declaration of IVAN POULLAOS in Support of Motion, # 2 Exhibit 1 Joint Ltr to Judge Almonte with redactions, # 3 Exhibit 2 Index of Confidential Information, # 4 Text of Proposed Order)(WEIDER, DOUGLAS) (Entered: 02/20/2024) (0) |
| Feb 15, 2024 | 76 | Transcript of Status Conference held on February 13, 2024, before Magistrate Judge Jose R. Almonte. Transcriber: King Transcription Services (973-237-6080). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Transcription Agency due, but not filed, by 3/7/2024. Redacted Transcript Deadline set for 3/18/2024. Release of Transcript Restriction set for 5/15/2024. (adc) (Entered: 02/15/2024) (0) |
| Feb 13, 2024 | 75 | TEXT ORDER: The parties shall meet and confer in good faith regarding the disputes raised at ECF No. 74 by February 20, 2024. To the extent the parties are unable to resolve the disputes, the parties shall brief the remaining disputes as follows: Plaintiffs shall file their opening brief by February 27, 2024. Defendants response shall be filed by March 12, 2024. Plaintiffs' reply, if any, shall be filed by March 19, 2024. The Court will resolve the remaining disputes at an in-person discovery dispute hearing scheduled for April 24, 2024, at 10:00 a.m. The parties shall appear in person at the Frank R. Lautenberg Post Office and U.S. Courthouse, 2 Federal Square, Courtroom 9, Newark, New Jersey. To the extent Defendants seek to file a motion concerning Plaintiffs' infringement contentions, any motion shall be filed in accordance with the aforementioned briefing schedule. So Ordered by Magistrate Judge Jose R. Almonte on 2/13/2024. (akw, ) (Entered: 02/14/2024) (0) |
| Feb 7, 2024 | 73 | LETTER ORDER granting the request for a one-day extension, until 2/7/2024, of the deadline to file status letters that are due in advance of the 2/13/2024 status conference. Signed by Magistrate Judge Jose R. Almonte on 2/7/2024. (wh) (Entered: 02/07/2024) (1) |
| Feb 7, 2024 | 74 | Letter from Charles H. Chevalier, Esq. to the Honorable Jose R. Almonte, U.S.M.J.. (CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 02/07/2024) (0) |
| Feb 6, 2024 | 72 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. (CHEVALIER, CHARLES) (Entered: 02/06/2024) (1) |
| Jan 23, 2024 | 71 | LETTER ORDER granting the parties' 70 Letter request for an extension of Markman deadlines. Signed by Magistrate Judge Jose R. Almonte on 1/23/2024. (mxw, ) (Entered: 01/23/2024) (2) |
| Jan 22, 2024 | 70 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. (CHEVALIER, CHARLES) (Entered: 01/22/2024) (2) |
| Dec 26, 2023 | 69 | BRIEF AMENDED Defendants' Opening Claim Construction Brief (WEIDER, DOUGLAS) (Entered: 12/26/2023) (30) |
| Dec 22, 2023 | 66 | MARKMAN OPENING BRIEF (Attachments: # 1 Declaration of Lauren Watt, Esq., # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17)(CHEVALIER, CHARLES) (Entered: 12/22/2023) (0) |
| Dec 22, 2023 | 67 | BRIEF Opening Claim Construction (WEIDER, DOUGLAS) (Entered: 12/22/2023) (30) |
| Dec 22, 2023 | 68 | DECLARATION re 67 Brief Opening Claim Construction by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (Attachments: # 1 Exhibit 1 U.S. Patent No. 10,626,088, # 2 Exhibit 2 U.S. Patent No. 11,060,128, # 3 Exhibit 3 U.S. Patent No. 11,268,128, # 4 Exhibit 4 U.S. Patent No. 11,274,331, # 5 Exhibit 5 U.S. Patent No. 11,274,332, # 6 Exhibit 6 Morris, # 7 Exhibit 7 Munowitz, # 8 Exhibit 8 Thomas, # 9 Exhibit 9 Shewale, # 10 Exhibit 10 Mahata, # 11 Exhibit 11 Pande, # 12 Exhibit 12 Sabbagh, # 13 Exhibit 13 Walraven, # 14 Exhibit 14 Bolt, # 15 Exhibit 15 Garcia-Martin, # 16 Exhibit 16 McDonagh, # 17 Exhibit 17 Fukunaga, # 18 Exhibit 18 Jetter, # 19 Exhibit 19 Chen, # 20 Exhibit 20 Morris, # 21 Declaration Dr. Pleasure, # 22 Declaration Dr. Lepore)(WEIDER, DOUGLAS) (Entered: 12/22/2023) (0) |
| Dec 8, 2023 | 65 | TEXT ORDER: Plaintiffs' request for an emergency status conference (ECF No. 64 ) is DENIED. The parties shall continue to exchange discovery in accordance with the Court's Pretrial Scheduling Order (ECF No. 33 ). However, the Court reminds the parties of their obligation to conduct discover in good faith. To the extent that any party engages in gamesmanship or acts in bad faith, this Court will impose necessary sanctions. Prior to the next status conference, the parties shall include in their JOINT letter, the efforts that they have made to meet and confer ONLY via video conference or in person to resolve these issues. So Ordered by Magistrate Judge Jose R. Almonte on 12/8/2023. (akw) (Entered: 12/12/2023) (0) |
| Dec 7, 2023 | 64 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. (CHEVALIER, CHARLES) (Entered: 12/07/2023) (2) |
| Dec 5, 2023 | 62 | MOTION for Leave to Appear Pro Hac Vice by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (Attachments: # 1 Declaration Weider Declaration re Sharon Lin pro hac, # 2 Declaration Sharon Lin Declaration, # 3 Text of Proposed Order)(WEIDER, DOUGLAS) (Entered: 12/05/2023) (0) |
| Dec 5, 2023 | 63 | ORDER granting 62 Motion for Leave for SHARON LIN, ESQ. to Appear Pro Hac Vice. Signed by Magistrate Judge Jose R. Almonte on 12/5/2023. (mxw, ) (Entered: 12/05/2023) (3) |
| Nov 13, 2023 | 61 | LETTER ORDER granting Defendant's 60 Letter request to extend the deadline for producing the API samples to 12/8/2023. Signed by Magistrate Judge Jose R. Almonte on 11/13/2023. (mxw, ) (Entered: 11/13/2023) (2) |
| Nov 10, 2023 | 60 | Letter from Douglas Weider re samples. (WEIDER, DOUGLAS) (Entered: 11/10/2023) (2) |
| Oct 30, 2023 | 58 | STATEMENT JOINT CLAIM CONSTRUCTION AND PREHEARING STATEMENT by All Plaintiffs. (CHEVALIER, CHARLES) (Entered: 10/30/2023) (30) |
| Oct 30, 2023 | 59 | TEXT ORDER: By November 17, 2023, Defendants shall produce samples of the ANDA product and active pharmaceutical ingredient as requested by Plaintiffs and as identified in the parties' joint status letter (ECF No. 57 ). A status conference is scheduled for February 13, 2024, at 2:00 p.m. For the conference, please dial 973-437-5535 and enter Phone Conference ID: 455 187 757#. No later than February 6, 2024, the parties shall file a joint letter not to exceed five (5) pages summarizing the status of the case. To the extent the parties wish to raise a discovery dispute, they shall do so consistent with the Court's Case Management Order. So Ordered by Magistrate Judge Jose R. Almonte on 10/30/2023. (akw) (Entered: 11/01/2023) (0) |
| Oct 24, 2023 | 55 | JOINT STIPULATION AND ORDER REGARDING DISCOVERY OF ELECTRONICALLY STORED INFORMATION. Signed by Magistrate Judge Jose R. Almonte on 10/24/2023. (mxw, ) (Entered: 10/24/2023) (10) |
| Oct 24, 2023 | 56 | LETTER ORDER granting the parties' 54 Letter request for an extension until 10/24/2023 of the deadline to file status letters. Signed by Magistrate Judge Jose R. Almonte on 10/24/2023. (mxw, ) (Entered: 10/24/2023) (1) |
| Oct 24, 2023 | 57 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. (CHEVALIER, CHARLES) (Entered: 10/24/2023) (4) |
| Oct 23, 2023 | 54 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte. (CHEVALIER, CHARLES) (Entered: 10/23/2023) (1) |
| Oct 10, 2023 | 53 | STIPULATION Joint Stipulation Regarding Discovery of Electronically Stored Information by CATALYST PHARMACEUTICALS, INC., SERB SA. (CHEVALIER, CHARLES) (Entered: 10/10/2023) (10) |
| Oct 6, 2023 | 52 | Letter from Douglas Weider re: Indefiniteness. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(WEIDER, DOUGLAS) (Entered: 10/06/2023) (0) |
| Sep 29, 2023 | 51 | LETTER ORDER granting Defendants' 50 Letter request for an extension until 10/2/2023 of time for the parties to exchange preliminary proposed constructions and identifications of extrinsic evidence. Signed by Magistrate Judge Jose R. Almonte on 9/29/2023. (mxw) (Entered: 09/29/2023) (1) |
| Sep 28, 2023 | 50 | Letter from Douglas Weider, Esq. re: Consent Order. (WEIDER, DOUGLAS) (Entered: 09/28/2023) (1) |
| Aug 4, 2023 | 48 | NOTICE of Change of Address by CHARLES H. CHEVALIER (CHEVALIER, CHARLES) (Entered: 08/04/2023) (3) |
| Aug 4, 2023 | 49 | *REDACTED* Transcript of Rule 16 Hearing held on May 1, 2023, before Magistrate Judge Jose R. Almonte. Transcriber: King Transcription Services (973-237-6080). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Transcription Agency due, but not filed, by 8/25/2023. Redacted Transcript Deadline set for 9/5/2023. Release of Transcript Restriction set for 11/2/2023. (adc) (Entered: 08/07/2023) (31) |
| Jul 25, 2023 | 46 | Letter from Charles H. Chevalier to the Honorable Jose R. Almonte, U.S.M.J.. (CHEVALIER, CHARLES) (Entered: 07/25/2023) (1) |
| Jul 25, 2023 | 47 | TEXT ORDER: In light of the status of this matter (ECF No. 45), the status conference scheduled for July 31, 2023 is adjourned to October 30, 2023, at 3:00 p.m. Please dial (888) 684-8852 and enter access code 1364268. No later than October 23, 2023, the parties shall file a joint letter not to exceed five (5) pages summarizing the status of the case. To the extent the parties wish to raise a discovery dispute, they shall do so consistent with the Courts Case Management Order. So Ordered by Magistrate Judge Jose R. Almonte on 7/25/2023. (akw) (Entered: 07/25/2023) (0) |
| Jul 24, 2023 | 45 | Letter from Charles H. Chevalier to the Honorable Jose R. Almonte, U.S.M.J.. (CHEVALIER, CHARLES) (Entered: 07/24/2023) (2) |
| Jun 12, 2023 | 44 | ORDER granting 40 Motion to Redact 34 Transcript. Signed by Magistrate Judge Jose R. Almonte on 6/12/2023. (wh) (Entered: 06/12/2023) (2) |
| May 24, 2023 | 43 | TEXT ORDER REASSIGNING CASE. Case reassigned to Judge Michael E. Farbiarz for all further proceedings. Judge Madeline Cox Arleo no longer assigned to case. So Ordered by Chief Judge Renee Marie Bumb on 5/24/23. (ak, ) (Entered: 05/24/2023) (0) |
| May 23, 2023 | 42 | Discovery Confidentiality Order. Signed by Magistrate Judge Jose R. Almonte on 5/23/2023. (mxw) (Entered: 05/23/2023) (27) |
| May 22, 2023 | 41 | Letter from Charles H. Chevalier to the Honorable Jose R. Almonte, U.S.M.J.. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 05/22/2023) (0) |
| May 19, 2023 | 40 | MOTION to Redact and Seal Transcript/Digital Recording 34 Transcript,,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Declaration of Charles H. Chevalier, # 2 Index, # 3 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 05/19/2023) (0) |
| May 19, 2023 | N/A | Set Deadlines as to 40 MOTION to Redact and Seal Transcript/Digital Recording 34 Transcript,,, . Motion set for 6/20/2023 before Judge Madeline Cox Arleo. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (mxw) (Entered: 05/19/2023) (0) |
| May 15, 2023 | 39 | LETTER ORDER granting 38 Letter request to adjourn the deadline to submit a Discovery Confidentiality Order until 5/22/2023. Signed by Magistrate Judge Jose R. Almonte on 5/13/2023. (mxw) (Entered: 05/15/2023) (2) |
| May 12, 2023 | 38 | Letter from Charles H. Chevalier to the Honorable Jose R. Almonte, U.S.M.J.. (CHEVALIER, CHARLES) (Entered: 05/12/2023) (2) |
| May 9, 2023 | 36 | Letter from Charles H. Chevalier to the Honorable Jose R. Almonte, U.S.M.J.. (CHEVALIER, CHARLES) (Entered: 05/09/2023) (1) |
| May 9, 2023 | 37 | LETTER ORDER granting Plaintiffs' 36 Letter request for an extension until 5/12/2023 to file a proposed Discovery Confidentiality Order. Signed by Magistrate Judge Jose R. Almonte on 5/9/2023. (mxw) (Entered: 05/10/2023) (1) |
| May 8, 2023 | 35 | TEXT ORDER: The Court has held an initial scheduling conference in all three related matters: 23-1194 (Catalyst Pharms. Inc., et al. v. Annora Pharma Private Ltd., et al.), 23-1197 (Catalyst Pharms. Inc., et al. v. Lupin, et al.), and 23-1190 (Catalyst Pharms. Inc., et al. v. Teva Pharms., Inc., et al.). In all three matters, Plaintiffs requested that the Court impose the deadline for Defendants to produce Federal Drug Administration (FDA) correspondence pursuant to L. Pat. R. 3.6(j)(2). Defendants Teva Pharms., Inc., et al., during the May 1, 2023 conference, and Defendants Annora Pharma Private Ltd., et al. and Lupin Ltd. et al., during the May 8, 2023 conference, requested an extension to the Rule (to allow 14 days). Initially, during the conference in the 23-1190 matter, this Court issued a Pretrial Scheduling Order allowing Teva to produce FDA correspondence within 10 days of receipt, rather than the 14 days it requested or the 7 days called for under the Rule. On May 8, 2023, the Court held an initial conference in the other related matters. The Court now has a better understanding of Plaintiffs position and agrees that, although the 7-day deadline might impose time constraints on Defendants, those constraints are not unique to the Defendants. The Court, therefore, reconsiders its prior decision and requires all Defendants to produce FDA correspondence pursuant to L. Pat. R. 3.6(j)(2). Additionally, the Court further amends the pre-trial scheduling order to include that all sur-reply expert reports on objective indica shall be delivered by April 4, 2025. So Ordered by Magistrate Judge Jose R. Almonte on 5/8/2023. (smf) (Entered: 05/08/2023) (0) |
| May 5, 2023 | 34 | Transcript of Initial Pretrial Conference held on May 1, 2023, before Magistrate Judge Jose R. Almonte. *SEALED* Pursuant to Order 44 . Transcriber: King Transcription Services (973-237-6080). CLERK'S NOTE: This is the complete unredacted/sealed version of the transcript and is unavailable for public viewing. (adc) Modified on 6/12/2023 (adc). (Entered: 05/08/2023) (0) |
| May 4, 2023 | 33 | PRETRIAL SCHEDULING ORDER. Signed by Magistrate Judge Jose R. Almonte on 5/4/2023. (mxw) (Entered: 05/04/2023) (5) |
| May 3, 2023 | 32 | Letter from Defendants to Judge Almonte re schedule and consolidation re 31 Order,. (WEIDER, DOUGLAS) (Entered: 05/03/2023) (2) |
| May 1, 2023 | N/A | Minute Entry for proceedings held before Magistrate Judge Jose R. Almonte: Initial Pretrial Conference held on 5/1/2023. Defendants are directed to discuss the issues raised during the status conference regarding the proposed scheduling order with Defendants' counsel in the related matters, 23-cv-1194 and 23-cv-1197, and update the Court as to the outcome of those discussions by no later than May 3, 2023. (Court Reporter, ECR (AT&T)) (smf) (Entered: 05/01/2023) (0) |
| May 1, 2023 | 31 | TEXT ORDER: Defendants are directed to discuss the issues raised during the status conference regarding the proposed scheduling order with defendants' counsel in the related matters, 23-cv-1194 and 23-cv-1197. By May 3, 2023, Defendants shall file a letter to notify the Court as to the consensus of all defendants regarding the scheduling order. So Ordered by Magistrate Judge Jose R. Almonte on 5/1/2023. (smf) (Entered: 05/01/2023) (0) |
| Apr 24, 2023 | 30 | ANSWER to Counterclaim by CATALYST PHARMACEUTICALS, INC., SERB SA.(CHEVALIER, CHARLES) (Entered: 04/24/2023) (27) |
| Apr 20, 2023 | 28 | Joint Discovery Plan by All Plaintiffs. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 04/20/2023) (0) |
| Apr 20, 2023 | 29 | TEXT ORDER: The initial scheduling conference set for April 25, 2023 is adjourned to May 1, 2023, at 10:30 a.m.. So Ordered by Magistrate Judge Jose R. Almonte on 4/20/2023. (akw) (Entered: 04/21/2023) (0) |
| Apr 17, 2023 | 27 | STIPULATION OF DISMISSAL OF COMPLAINT AS TO DEFENDANT TEVA PHARMACEUTICAL INDUSTRIES LTD. AND AMENDMENT OF CAPTION. Signed by Judge Madeline Cox Arleo on 4/17/2023. (mxw) (Entered: 04/17/2023) (4) |
| Apr 5, 2023 | 25 | ORDER granting 24 Motion for GEORGE C. LOMBARDI, ESQ., IVAN M. POULLAOS, ESQ., ALISON KING, ESQ., and BRIAN L. OGARA, ESQ. to Appear Pro Hac Vice. Signed by Magistrate Judge Jose R. Almonte on 4/5/2023. (mxw) (Entered: 04/05/2023) (3) |
| Apr 5, 2023 | 26 | AO120 Patent/Trademark Form filed. (Attachments: # 1 Complaint) (mxw) (Entered: 04/05/2023) (0) |
| Apr 5, 2023 | N/A | Pro Hac Vice counsel, ADAM C. LAROCK, JOSEPHINE KIM, LAUREN A. WATT, CHRISTOPHER M. GALLO, PHD, JOSEPH H. KIM, ALEXANDER ALFANO, DAVIN B. GUINN and RYAN E. CONKIN, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (mxw) (Entered: 04/05/2023) (0) |
| Apr 4, 2023 | 16 | Notice of Request by Pro Hac Vice Adam C. LaRock to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219910.) (CHEVALIER, CHARLES) (Entered: 04/04/2023) (1) |
| Apr 4, 2023 | 17 | Notice of Request by Pro Hac Vice Josephine Kim to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219915.) (CHEVALIER, CHARLES) (Entered: 04/04/2023) (1) |
| Apr 4, 2023 | 18 | Notice of Request by Pro Hac Vice Lauren A. Watt to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219919.) (CHEVALIER, CHARLES) (Entered: 04/04/2023) (1) |
| Apr 4, 2023 | 19 | Notice of Request by Pro Hac Vice Christopher M. Gallo, Ph.D. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219927.) (CHEVALIER, CHARLES) (Entered: 04/04/2023) (1) |
| Apr 4, 2023 | 20 | Notice of Request by Pro Hac Vice Joseph H. Kim to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219931.) (CHEVALIER, CHARLES) (Entered: 04/04/2023) (1) |
| Apr 4, 2023 | 21 | Notice of Request by Pro Hac Vice Alexander Alfano to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219932.) (CHEVALIER, CHARLES) (Entered: 04/04/2023) (1) |
| Apr 4, 2023 | 22 | Notice of Request by Pro Hac Vice Davin B. Guinn to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219934.) (CHEVALIER, CHARLES) (Entered: 04/04/2023) (1) |
| Apr 4, 2023 | 23 | Notice of Request by Pro Hac Vice Ryan E. Conkin to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14219940.) (CHEVALIER, CHARLES) (Entered: 04/04/2023) (1) |
| Apr 4, 2023 | 24 | MOTION for Leave to Appear Pro Hac Vice by TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC.. (Attachments: # 1 Declaration Weider Declaration, # 2 Declaration Alison King Declaration ISO of Pro Hac Vice Admission, # 3 Declaration Lombardi Declaration ISO of Pro Hac Vice Admission, # 4 Declaration O'Gara Declaration ISO of Pro Hac Vice Admission, # 5 Declaration Poullaos Declaration ISO of Pro Hac Vice Admission, # 6 Text of Proposed Order Proposed Order)(WEIDER, DOUGLAS) (Entered: 04/04/2023) (0) |
| Apr 3, 2023 | 12 | Consent MOTION for Leave to Appear Pro Hac Vice by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Declaration of Charles H. Chevalier, # 2 Declaration of Adam C. LaRock, # 3 Declaration of Josephine Kim, # 4 Declaration of Lauren A. Watt, # 5 Declaration of Christopher M. Gallo, Ph.D., # 6 Declaration of Joseph H. Kim, # 7 Declaration of Alexander Alfano, # 8 Declaration of Davin B. Guinn, # 9 Declaration of Ryan E. Conkin, # 10 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 04/03/2023) (0) |
| Apr 3, 2023 | 13 | ANSWER to Complaint , COUNTERCLAIM against All Plaintiffs by All Defendants.(WEIDER, DOUGLAS) (Entered: 04/03/2023) (30) |
| Apr 3, 2023 | 14 | Corporate Disclosure Statement by TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. identifying Teva Ltd. as Corporate Parent.. (WEIDER, DOUGLAS) (Entered: 04/03/2023) (3) |
| Apr 3, 2023 | 15 | ORDER granting 12 Motion for Leave to Appear Pro Hac Vice as to ADAM C. LAROCK, ESQ., JOSEPHINE KIM, ESQ., LAUREN A. WATT, ESQ., CHRISTOPHER M. GALLO, PH.D., ESQ., JOSEPH H. KIM, ALEXANDR ALFANO, ESQ., DAVIN B. GUINN, ESQ., and RYAN E. CONKIN, ESQ. Signed by Magistrate Judge Jose R. Almonte on 4/3/2023. (lag, ) (Entered: 04/03/2023) (4) |
| Mar 31, 2023 | 11 | STIPULATION of Dismissal of Complaint and Amendment of Caption by TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (WEIDER, DOUGLAS) (Entered: 03/31/2023) (4) |
| Mar 27, 2023 | 10 | NOTICE of Appearance by DENNIES VARUGHESE on behalf of All Plaintiffs (VARUGHESE, DENNIES) (Entered: 03/27/2023) (1) |
| Mar 23, 2023 | 9 | NOTICE of Appearance by CHRISTINE A. GADDIS on behalf of CATALYST PHARMACEUTICALS, INC., SERB SA (GADDIS, CHRISTINE) (Entered: 03/23/2023) (1) |
| Mar 16, 2023 | 6 | SUMMONS Returned Executed by CATALYST PHARMACEUTICALS, INC., SERB SA. TEVA PHARMACEUTICALS, INC. served on 3/13/2023, answer due 4/3/2023. (CHEVALIER, CHARLES) (Entered: 03/16/2023) (3) |
| Mar 16, 2023 | 7 | SUMMONS Returned Executed by CATALYST PHARMACEUTICALS, INC., SERB SA. TEVA PHARMACEUTICALS USA, INC. served on 3/13/2023, answer due 4/3/2023. (CHEVALIER, CHARLES) (Entered: 03/16/2023) (3) |
| Mar 16, 2023 | 8 | SUMMONS Returned Executed by CATALYST PHARMACEUTICALS, INC., SERB SA. TEVA PHARMACEUTICAL INDUSTRIES LIMITED served on 3/13/2023, answer due 4/3/2023. (CHEVALIER, CHARLES) (Entered: 03/16/2023) (3) |
| Mar 8, 2023 | 5 | LETTER ORDER Pursuant to Local Civil Rule 16.1. On 4/25/2023 at 3:30 PM there shall be an Initial Scheduling Conference before Magistrate Judge Jose R. Almonte, etc. Signed by Magistrate Judge Jose R. Almonte on 3/8/2023. (smf) (Entered: 03/08/2023) (3) |
| Mar 2, 2023 | N/A | Magistrate Judge Jose R. Almonte added. (ps) (Entered: 03/02/2023) (0) |
| Mar 1, 2023 | 1 | COMPLAINT against TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-14125181), filed by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet, # 8 Certification Pursuant to Local Civil Rule 11.2)(CHEVALIER, CHARLES) (Entered: 03/01/2023) (0) |
| Mar 1, 2023 | 2 | Corporate Disclosure Statement by CATALYST PHARMACEUTICALS, INC. identifying NONE as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 03/01/2023) (2) |
| Mar 1, 2023 | 3 | Corporate Disclosure Statement by SERB SA identifying NONE as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 03/01/2023) (2) |
| Mar 1, 2023 | 4 | SUMMONS ISSUED as to TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (mxw, ) (Entered: 03/01/2023) (2) |
